Members of Congress have called on the Centers for Disease Control and Prevention to establish tracking systems for parental refusals of vitamin K injections for newborns, citing a ProPublica investigation into the practice.
Vitamin K shots prevent hemorrhagic disease of the newborn, a rare but potentially fatal bleeding disorder. The CDC recommends all newborns receive the injection within the first hour of life. Declining the shot carries documented health risks, yet some parents refuse based on alternative medicine beliefs or concerns about vaccine ingredients.
The lawmakers' letter directs the CDC to implement surveillance systems similar to those tracking vaccine hesitancy nationwide. Such tracking would identify geographic clusters of refusals and enable public health officials to respond with targeted education campaigns. Existing data collection remains fragmented across individual hospitals and state health departments, creating gaps in the national picture.
ProPublica's investigation documented cases where newborns suffered serious bleeding complications after parents declined vitamin K prophylaxis. The reporting prompted renewed attention to the practice among policymakers concerned about preventable harm to infants.
The CDC currently lacks comprehensive federal data on vitamin K refusal rates. State laws vary on informed consent requirements and parental notification procedures before administering the injection. Some states require written documentation of refusals, while others rely on verbal consent frameworks that generate inconsistent records.
Public health advocates argue that systematic tracking enables evidence-based interventions without infringing parental rights. The CDC can identify communities where misinformation about vitamin K spreads and deploy corrective messaging through healthcare providers and community health workers.
The request reflects broader congressional scrutiny of the CDC's surveillance infrastructure following the COVID-19 pandemic. Lawmakers argue stronger data collection capabilities improve the agency's capacity to detect emerging public health threats.
Vitamin K refusals remain statistically rare nationally, occurring in fewer than 2 percent of births. However, regional variations suggest concentrations in areas